Carisma Therapeutics, Inc.股价拉升225.35% 市值涨6948.67万美元

市场透视2025-06-10

北京时间2025年06月10日21时31分，Carisma Therapeutics, Inc.（CARM.us）股票出现波动，股价急速上涨225.35%。截至发稿，该股报0.738美元/股，成交量1.86701亿股，换手率446.78%，振幅12.57%。最近的财报数据显示，该股实现营业收入3.73百万美元，净利润-9.27百万美元，每股收益-0.22美元，毛利2.19百万美元，市盈率-0.60...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2542023317?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-10 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2542023317","market":"us","top_or_hot":-1,"title":"Carisma Therapeutics, Inc.股价拉升225.35% 市值涨6948.67万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年06月10日21时31分，Carisma Therapeutics, Inc.（CARM.us）股票出现波动，股价急速上涨225.35%。截至发稿，该股报0.738美元/股，成交量1.86701亿股，换手率446.78%，振幅12.57%。最近的财报数据显示，该股实现营业收入3.73百万美元，净利润-9.27百万美元，每股收益-0.22美元，毛利2.19百万美元，市盈率-0.60...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213119a70238a6&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Carisma Therapeutics, Inc.股价拉升225.35% 市值涨6948.67万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCarisma Therapeutics, Inc.股价拉升225.35% 市值涨6948.67万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-10 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213119a70238a6&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年06月10日21时31分，Carisma Therapeutics, Inc.（CARM.us）股票出现波动，股价急速上涨225.35%。截至发稿，该股报0.738美元/股，成交量1.86701亿股，换手率446.78%，振幅12.57%。最近的财报数据显示，该股实现营业收入3.73百万美元，净利润-9.27百万美元，每股收益-0.22美元，毛利2.19百万美元，市盈率-0.60...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213119a70238a6&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213119a70238a6&s=b","article_id":"2542023317","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213119a70238a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2542023317","pubTimestamp":1749562279,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年06月10日21时31分，Carisma Therapeutics, Inc.股票出现波动，股价急速上涨225.35%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","BK4539":"次新股","BK4139":"生物科技","CARM":"Carisma Therapeutics, Inc.","BK4007":"制药"},"translate_title":"Carisma Therapeutics, Inc. 's stock price rose 225.35%, its market value rose by $69.4867 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"CARM":1},"content_text":"北京时间2025年06月10日21时31分，Carisma Therapeutics, Inc.（CARM.us）股票出现波动，股价急速上涨225.35%。截至发稿，该股报0.738美元/股，成交量1.86701亿股，换手率446.78%，振幅12.57%。最近的财报数据显示，该股实现营业收入3.73百万美元，净利润-9.27百万美元，每股收益-0.22美元，毛利2.19百万美元，市盈率-0.60倍。机构评级方面，在所有2家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Carisma Therapeutics, Inc.、Evogene Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)涨幅较大，Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃，换手率分别为6434.23%、1521.72%、807.58%，振幅较大的相关个股有Carisma Therapeutics, Inc.、Windtree Therapeutics, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 (To Pur Com)，振幅分别为47.35%、17.66%、15.61%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2542023317","isCrawlerRequest":true}